Quoin Pharmaceuticals QNRX
NASDAQ QNRX
$3.98 +0.08 (+2.05%)
At close: Oct 19, 2026 · 4:00 PM EDT

Quoin Pharmaceuticals (QNRX) Operating Interest Expenses (2021)

Updated

Quoin Pharmaceuticals' Operating Interest Expenses was $275,000 in the year ended Dec 31, 2021.

Analysis

Quoin Pharmaceuticals (QNRX) Operating Interest Expenses (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Interest Exp. (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn -
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn -
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn -
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn -
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn -
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn -
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn -
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn -
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn -
10 Quoin Pharmaceuticals 323,761.71 -45.14 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 185,000.00
API Access

Quoin Pharmaceuticals Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-interest-expenses&ticker=QNRX&period=max&api_key=YOUR_API_KEY